Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis.
暂无分享,去创建一个
[1] Wenyan Lu,et al. Sorting nexin 17 facilitates LRP recycling in the early endosome , 2005, The EMBO journal.
[2] K. Weisgraber,et al. The recycling of apolipoprotein E in macrophages: influence of HDL and apolipoprotein A-I. , 2005, Journal of lipid research.
[3] M. Farlow,et al. Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease Published, JLR Papers in Press, February 16, 2005. DOI 10.1194/jlr.M400486-JLR200 , 2005, Journal of Lipid Research.
[4] Yonghe Li,et al. Rapid Endocytosis of the Low Density Lipoprotein Receptor-related Protein Modulates Cell Surface Distribution and Processing of the β-Amyloid Precursor Protein* , 2005, Journal of Biological Chemistry.
[5] Dipak P. Ramji,et al. The key role of apolipoprotein E in atherosclerosis , 2005, Journal of Molecular Medicine.
[6] K. Rye,et al. Impaired Recycling of Apolipoprotein E4 Is Associated with Intracellular Cholesterol Accumulation* , 2004, Journal of Biological Chemistry.
[7] I. Goldberg,et al. Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk , 2004, Current atherosclerosis reports.
[8] Jonathan C. Cohen,et al. The Modular Adaptor Protein ARH Is Required for Low Density Lipoprotein (LDL) Binding and Internalization but Not for LDL Receptor Clustering in Coated Pits* , 2004, Journal of Biological Chemistry.
[9] K. Weisgraber,et al. The recycling of apolipoprotein E and its amino-terminal 22 kDa fragment: evidence for multiple redundant pathways. , 2004, Journal of lipid research.
[10] B. Hyman,et al. Serine and Threonine Phosphorylation of the Low Density Lipoprotein Receptor-related Protein by Protein Kinase Cα Regulates Endocytosis and Association with Adaptor Molecules* , 2004, Journal of Biological Chemistry.
[11] R. Binder,et al. Essential role of CD91 in re-presentation of gp96-chaperoned peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[12] H. Brewer,et al. The ABCA1 Transporter Modulates Late Endocytic Trafficking , 2004, Journal of Biological Chemistry.
[13] R. Havel,et al. Endocytosis of Hepatic Lipase and Lipoprotein Lipase into Rat Liver Hepatocytes in Vivo Is Mediated by the Low Density Lipoprotein Receptor-related Protein* , 2004, Journal of Biological Chemistry.
[14] L. Lanningham-Foster,et al. Harmful Effects of Increased LDLR Expression in Mice With Human APOE*4 But Not APOE*3 , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[15] K. Weisgraber,et al. Effects of Polymorphism on the Lipid Interaction of Human Apolipoprotein E* , 2003, Journal of Biological Chemistry.
[16] J. Heeren,et al. Recycling of Apoprotein E Is Associated with Cholesterol Efflux and High Density Lipoprotein Internalization* , 2003, The Journal of Biological Chemistry.
[17] M. Linton,et al. The Recycling of Apolipoprotein E in Primary Cultures of Mouse Hepatocytes , 2003, The Journal of Biological Chemistry.
[18] C. Haass,et al. Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts , 2003, The Journal of cell biology.
[19] G. Kolovou,et al. Apolipoprotein E Polymorphism and Atherosclerosis , 2003, Angiology.
[20] B. Rupp,et al. Apolipoprotein E4 Forms a Molten Globule , 2002, The Journal of Biological Chemistry.
[21] R. Eckel,et al. Lipoprotein lipase : genetics , lipid uptake , and regulation , 2002 .
[22] Jonathan C. Cohen,et al. ARH Is a Modular Adaptor Protein That Interacts with the LDL Receptor, Clathrin, and AP-2* , 2002, The Journal of Biological Chemistry.
[23] M. Wolfe. Therapeutic strategies for Alzheimer's disease , 2002, Nature Reviews Drug Discovery.
[24] R. E. Pitas,et al. Evidence for differential effects of apoE3 and apoE4 on HDL metabolism Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200172-JLR200 , 2002, Journal of Lipid Research.
[25] Kai Simons,et al. Cholesterol, lipid rafts, and disease. , 2002, The Journal of clinical investigation.
[26] J. Heeren,et al. Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo , 2002, Journal of Molecular Medicine.
[27] A. Horwitz,et al. Evaluation of the Role of Phosphatidylserine Translocase Activity in ABCA1-mediated Lipid Efflux* , 2002, The Journal of Biological Chemistry.
[28] S. Younkin,et al. Cholesterol-Dependent γ-Secretase Activity in Buoyant Cholesterol-Rich Membrane Microdomains , 2002, Neurobiology of Disease.
[29] S. Younkin,et al. Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. , 2002, Neurobiology of disease.
[30] J. Heeren,et al. Recycling of Apolipoprotein E and Lipoprotein Lipase through Endosomal Compartments in Vivo * , 2001, The Journal of Biological Chemistry.
[31] Robert V Farese,et al. Introduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[32] H. Brewer,et al. Regulation and intracellular trafficking of the ABCA1 transporter. , 2001, Journal of lipid research.
[33] M. Linton,et al. A Recycling Pathway for Resecretion of Internalized Apolipoprotein E in Liver Cells* , 2001, The Journal of Biological Chemistry.
[34] J. Heeren,et al. Intracellular metabolism of triglyceride-rich lipoproteins , 2001, Current opinion in lipidology.
[35] Jonathan C. Cohen,et al. Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor Protein , 2001, Science.
[36] E. Kojro,et al. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10 , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[37] C. Bergmann,et al. Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[38] C. Schweiger. [Statins and the risk of dementia]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[39] M. Hennerici,et al. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[40] E. Kojro,et al. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[41] A. von Eckardstein,et al. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[42] D. Small,et al. Regulation of APP cleavage by α‐, β‐ and γ‐secretases , 2000 .
[43] D. Riddell,et al. Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice. , 2000, Human molecular genetics.
[44] P. Srivastava,et al. CD91: a receptor for heat shock protein gp96 , 2000, Nature Immunology.
[45] R. Walzem,et al. Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[46] L. Curtiss,et al. Apolipoprotein E and atherosclerosis. , 2000, Current opinion in lipidology.
[47] T. V. van Berkel,et al. Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo , 2000, The Journal of Biological Chemistry.
[48] Q. Fan,et al. Apolipoprotein E Exhibits Isoform‐Specific Promotion of Lipid Efflux from Astrocytes and Neurons in Culture , 2000, Journal of neurochemistry.
[49] D. Small,et al. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. , 2000, FEBS letters.
[50] R. Mahley,et al. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. , 1999, Journal of lipid research.
[51] K. Cianflone,et al. Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase. , 1999, Journal of lipid research.
[52] D. Rader,et al. Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[53] Masahiko Watanabe,et al. Apo E structure determines VLDL clearance and atherosclerosis risk in mice. , 1999, The Journal of clinical investigation.
[54] M. Linton,et al. Recycling of Apolipoprotein E in Mouse Liver* , 1999, The Journal of Biological Chemistry.
[55] C. Mamotte,et al. Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes. , 1999, The American journal of physiology.
[56] J. Heeren,et al. Intracellular processing of endocytosed triglyceride-rich lipoproteins comprises both recycling and degradation. , 1999, Journal of cell science.
[57] R. Mahley,et al. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. , 1999, Journal of lipid research.
[58] D. Dichek,et al. Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice. , 1998, The Journal of clinical investigation.
[59] B. Strooper,et al. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[60] R. Hammer,et al. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. , 1998, The Journal of clinical investigation.
[61] J. Heeren,et al. Lipoprotein lipase (EC 3.1.1.34) targeting of lipoproteins to receptors , 1997, Proceedings of the Nutrition Society.
[62] G. Siest,et al. Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors. , 1996, Journal of lipid research.
[63] A D Roses,et al. Apolipoprotein E alleles as risk factors in Alzheimer's disease. , 1996, Annual review of medicine.
[64] R. Havel,et al. Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele. , 1996, The Journal of clinical investigation.
[65] A. von Eckardstein,et al. Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma. , 1995, The Journal of clinical investigation.
[66] H. Brewer,et al. Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. , 1995, The Journal of clinical investigation.
[67] A. Mcclelland,et al. Phenotypic correction of hypercholesterolemia in apoE-deficient mice by adenovirus-mediated in vivo gene transfer. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[68] D. Agard,et al. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. , 1994 .
[69] N. Maeda,et al. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[70] Stephen W. Scheff,et al. Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol , 1994, Experimental Neurology.
[71] R. Frants,et al. Inefficient degradation of triglyceride-rich lipoprotein by HepG2 cells is due to a retarded transport to the lysosomal compartment. , 1993, The Journal of biological chemistry.
[72] F. Maxfield,et al. Beta-very low density lipoprotein is sequestered in surface-connected tubules in mouse peritoneal macrophages , 1993, The Journal of cell biology.
[73] V. Ord,et al. Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[74] J. Dallongeville,et al. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. , 1992, Journal of lipid research.
[75] F. Maxfield,et al. The influence of particle size and multiple apoprotein E-receptor interactions on the endocytic targeting of beta-VLDL in mouse peritoneal macrophages , 1991, The Journal of cell biology.
[76] G. Bengtsson-Olivecrona,et al. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[77] F. Maxfield,et al. Endocytosed beta-VLDL and LDL are delivered to different intracellular vesicles in mouse peritoneal macrophages , 1990, The Journal of cell biology.
[78] K. Weisgraber. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. , 1990, Journal of lipid research.
[79] U. Beisiegel,et al. The LDL–receptor–related protein, LRP, is an apolipoprotein E-binding protein , 1989, Nature.
[80] R. Gregg,et al. Abnormal in vivo metabolism of apolipoprotein E4 in humans. , 1986, The Journal of clinical investigation.
[81] M. Brown,et al. A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.
[82] R. Mahley,et al. Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. , 1981, The Journal of clinical investigation.
[83] E. Quinet,et al. Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. , 1980, The Journal of clinical investigation.
[84] J. Little,et al. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. , 1978, The New England journal of medicine.